Objectives: Curcumin has been shown to exhibit anti-neoplastic effects. However, due to its poor bioavailability, the use of curcumin as an anti-cancer drug is limited. Thus, it is necessary to identify molecules as an alternative to curcumin that could serve as anti-cancer targets. In this study, we attempted to understand the underlying curcumin-mediated signalling pathways contributing to anti-neoplastic effects of curcumin. Methods: We carried out mass spectrometry-based phosphoproteomic analysis of head and neck cancer cell line, CAL 27, treated with and without curcumin to identify curcumin-mediated signalling pathways. Serine/threonine kinases were enriched using titanium dioxide.
Introduction
Curcumin, chemically known as diferuloylmethane, is the active component derived from Curcuma longa L. Curcumin is known for its anti-inflammatory, anti-oxidant, anti-diabetic, anti-ageing and anti-neoplastic effects. 1 Curcumin is also a potent anti-bacterial agent and its use for anti-bacterial activity was demonstrated in 1949. 2 The anti-inflammatory activities of curcumin was first demonstrated in 1973 and over 100 clinical trials have been conducted using curcumin against various diseases. 3, 4 Curcumin is also used as an effective agent against various diseases such as cancer, obesity, pulmonary and cardiovascular diseases. 3 It is also reported to be a chemosentization and radiosensitization agent. 5 The anti-neoplastic effects of curcumin is demonstrated by its ability to inhibit cell proliferation, invasion and migration of multiple cancer types including breast, gastric, lung, and head and neck squamous cell carcinoma (HNSCC). 6 Curcumin exerts its effects by targeting multiple proteins such as enzymes, receptors, proteins implicated in cell signalling, cell cycle, regulation, various chemokines, cytokines and cell adhesion. 7 However, the use of curcumin is limited due to its low solubility and bioavailability, faster metabolism and rapid excretion from the system. 8, 9 However, several attempts are being made to overcome these problems that limit the utility of curcumin. One of the approaches that could be employed is to identify the downstream signalling pathways mediated by curcumin and target molecules pertaining to those pathways. We have previously reported perturbations in various tyrosine kinases in response to curcumin in HNSCC. 10 However, in our previous study, we did not study the role of altered kinases that could be targeted as an alternative to curcumin.
Serine/threonine kinases (STKs) play an important role in maintaining cellular homeostasis by regulating various transcription factors and cell cycle proteins. Dysregulation of STKs has been associated with various tumours where they are known to regulate tumour growth and metastasis. 11 To gain more insights into curcumin-mediated effects, in this study, we profiled STKs and their substrates regulated by curcumin. Stable isotope labeling with amino acids in cell culture (SILAC)-based phosphoproteomic analysis of an HNSCC cell line, CAL 27 treated with curcumin and/or dimethyl sulfoxide (DMSO) was carried out. Phosphoproteomic analysis of curcumin-treated CAL 27 cells resulted in the identification of 5921 phosphopeptides, among which 275 and 183 phosphopeptides were found to be hyper-and hypo-phosphorylated (2-fold), respectively, in response to curcumin treatment. Among the kinases dysregulated, calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2) was found to be hypo-phosphorylated at Ser-100 (0.3-fold) upon curcumin treatment.
CaMKK2, a non-receptor STK, is known to play a role in calcium/calmodulin-dependent kinase signalling cascade. 12 This signalling cascade plays an important role in cell proliferation, differentiation and metabolism. CaMKK2 has been reported to be elevated in gastric, prostate and hepatic cancers. [13] [14] [15] CaMKK2 has been shown to regulate growth, migration and progression of prostate cancer cells. 13, 16, 17 Previous study from our group demonstrated that silencing or inhibiting CaMKK2 activity inhibited cellular proliferation, colony formation and invasive ability of gastric cancer cells. 15 In this study, we determined the role of CaMKK2 as an alternative to curcumin in HNSCC.
Materials and methods

Cell culture conditions
CAL 27 and FaDu cells were purchased from the American Type Culture Collection (ATCC, Manassas, VA). JHU-O22, JHU-O28 and FaDu cells were grown in Roswell Park Memorial Institute (RPMI) medium supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin mixture. CAL 27 cells were grown and maintained in Dulbecco's Modified Eagle Medium (DMEM) containing 10% FBS and 1% penicillin/streptomycin mixture. All cells were grown at 37 C in a humidified incubator supplied with 5% CO 2 .
SILAC labelling and sample preparation for mass spectrometry analysis SILAC labelling of CAL 27 cells was carried out as described in our previous study. 10 CAL 27 cells grown in regular media were treated with curcumin at a dose of 11.5 mM for 4 h and cells cultured in SILAC media were treated with DMSO. Posttreatment, the cells from both the conditions were washed with 1Â phosphate buffered saline (PBS) and harvested in urea lysis buffer (20 mM (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) [HEPES] (pH8.0), 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate and 1 mM b-glycerophosphate). The samples were then sonicated and centrifuged at 13,000 rpm at 15 C for 20 min. Then, protein concentration was determined by bicinchoninic acid (BCA) assay 18 and equal amount of protein lysate from both the conditions was mixed and subjected to reduction, alkylation and protein digestion, as described previously. 10 
Basic reversed phase liquid chromatography fractionation
Peptides were fractionated by basic pH reverse phase liquid chromatography as described previously. 19 Briefly, 10 mg of lyophilized peptides mixture was resuspended in 1 ml of basic reversed phase liquid chromatography (bRPLC) solvent A (7 mM triethylammonium bicarbonate [TEABC], pH 8.5) and fractionated by bRPLC chromatography on a XBridge C18, 5 mm 250 mm Â 4.6 mm column (Waters, Milford, MA) by employing an increasing gradient of bRPLC solvent B (7 mM TEABC, pH 8.5, 90% acetonitrile) on an Agilent 1100 LC system (Agilent Technologies, Waldbronn, Germany). A total of 96 fractions were collected which were then concatenated into 12 fractions and lyophilized.
Enrichment of phosphopeptides using titanium dioxide
Titanium dioxide (TiO 2 )-based phosphopeptide enrichment of 12 fractions obtained was carried out as described by Larsen and group. 20 Briefly, TiO 2 beads were incubated with 2, 5-dihydroxybenzoic acid (DHB) solution (80% acetonitrile [ACN], 1% trifluoroacetic acid [TFA], 3% DHB) for 2-4 h at room temperature. Each fraction was resuspended in DHB and incubated with pre-treated TiO 2 beads (1 mg). Phosphopeptide-bound TiO 2 beads were washed three times with DHB solution and twice with 40% ACN. Peptides were eluted three times with 40 ml of 2% ammonia into 10 ml of 20% TFA.
LC-MS/MS and data analysis
LTQ-Orbitrap Velos mass spectrometer (Thermo Fischer Scientific, Bermen, Germany) interfaced with Proxeon Easy nLC system (Thermo Fischer Scientific) was used for the analysis of the bRPLC-fractionated phosphopeptides as described previously. 10 The raw data obtained were processed using Proteome Discoverer software suite version 1.4.1.14 (Thermo Fisher Scientific) and searched using Sequest and Mascot search algorithms against human RefSeq protein database 59 and trypsin as proteolytic enzyme. The search criteria included carbamidomethylation at cysteine as fixed modification, oxidation at methionine, phosphorylation at serine, threonine and tyrosine and SILAC labels 13 C 6 -Lysine; 13 C 6 -Arginine as variable modifications with maximum of two missed cleavage. Precursor and fragment mass tolerance were set to 20 ppm and 0.1 Da, respectively. The peptide and protein data were extracted using high peptide confidence and top one peptide rank filters. The data were also searched against a decoy database to calculate the false discovery rate (FDR). Peptide spectrum matches at 1% FDR were used for protein identifications. Precursor ion quantifier node was used for peptide quantification, and PhosphoRS node (version 3.1) was used for the calculation of phosphosite probabilities. Further phosphopeptides with phosphosite probabilities !75% were used for the identification of protein phosphorylation sites.
Availability of data
Data generated from mass spectrometry analysis has been submitted to and can be accessed at ProteomeXchange Consortium (http://www.proteomecentral.proteomexchange. org) via the PRIDE public data repository and can be accessed using the data identifier -PXD007256.
MTT assay
To determine the effects of curcumin on HNSCC cell viability, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was carried out as per manufacturer instructions (ATCC 30-1010K). Briefly, JHU-O22, JHU-O28 and FaDu cells were seeded at a density of 8 Â 10 3 and treated with varying doses of curcumin ranging from 0 to 25 mM for 48 h at 37
C. Post-incubation, MTT reagent was added and incubated for 2-4 h until purple formazan crystals formed. The purple crystals were solubilized using 100 ml detergent solution and the absorbance was read at 570 and 650 nm.
Colony formation and invasion assays
Colony formation and invasion assays of CAL 27, JHU-O22, JHU-O28, FaDu and CAL 27 cells were carried out as described previously. 21 
Western blot analysis
Western blot analysis of the samples was carried out as described previously. 21 Cells were grown to 70-80% confluence and proteins were harvested in radioimmunoprecipitation assay buffer (RIPA) lysis buffer (10 mM Tris pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton-X-100, 0.1% SDS containing protease and phosphatase inhibitor cocktails) and sonicated. The cell lysate of 30 mg was resolved by SDS-PAGE and transferred onto nitrocellulose membrane. The membrane was blocked with 5% nonfat dry milk or 5% bovine serum albumin in PBS-T and incubated overnight with indicated antibodies. Then secondary antibody was added and proteins on the membrane were visualized using enhanced chemiluminescence detection kit as per manufacturer's instructions. b-actin was used as a loading control. CaMKK2 antibody was purchased from Sigma (St Louis, Missouri, USA). Total AMPK-a and p-AMPK-a (T172) and total AMPK-b1 and p-AMPK-b1 (S108) were purchased from Cell Signaling Technology (Beverly, Massachusetts, USA).
Results
Identification of signalling pathways altered in response to curcumin
In our previous study, we reported that curcumin inhibits cellular proliferation, colony formation and invasion ability of HNSCC cell line, CAL 27. Mass spectrometry-based analysis revealed dysregulation of various tyrosine kinases which may be involved in the anti-neoplastic effects of curcumin. 10 In this study, we studied the effects of curcumin on STKs using quantitative mass spectrometry-based approach. We investigated the molecular alterations of curcumin-induced signalling using SILAC-based quantitative phosphoproteomic analysis. Cells treated with DMSO (control cells) were adapted to 'heavy' SILAC media, whereas the cells grown in 'regular' media were treated with curcumin for 4 h. Post-curcumin treatment, cells were harvested, lysed and equal amounts of lysates were pooled and digested with trypsin. The phospho-Ser/Thr peptides were enriched by TiO 2 -based enrichment method and analysed on LTQ-Orbitrap Velos mass spectrometer. The schematic workflow of SILAC-based phosphoproteomic analysis is shown in Figure 1 . The data acquired were processed and searched using the search algorithms, SEQUEST and MAS-COT, against human RefSeq database. This resulted in the identification of 5921 phosphopeptides corresponding to 1878 proteins. Among these, 275 and 183 phosphopeptides corresponding to 335 and 242 proteins were found to be hyperand hypo-phosphorylated (!2.0-fold) upon curcumin treatment, respectively. A complete list of proteins and their phosphopeptides is available on request from the authors.
Curcumin induces hyper-and hypo-phosphorylation of several STKs.
Mass spectrometry analysis revealed aberrations in various kinases and their downstream targets upon exposure of CAL 27 cells to curcumin. A partial list of proteins found to be hyper-and hypo-phosphorylated is given in Table 1 . Kinases including protein tyrosine kinase 2 (PTK2) (S910; 3.7-fold) and STK 17a (STK17A) (S28; 2.8-fold) were found to be hyper-phosphorylated in CAL 27 treated with curcumin. Other kinases including mitogen-activated protein kinase 1 (MAPK1), mitogen-activated protein kinase 3 (MAPK3) and protein kinase D2 (PRKD2) were found to be hypophosphorylated at multiple sites upon curcumin treatment (Table 1) . CaMKK2, an STK (S100; 0.33-fold), and its downstream targets including protein kinase, AMP-activated, beta 1 non-catalytic subunit (PRKAB1 or AMP-dependent protein kinase (AMPK)-b1) (S108-0.35), acetyl-CoA carboxylase 1 (ACC1 or ACACA) (S62, S66; 0.067; S60-0.084; S117-0.11), p21 protein (Cdc42/Rac)-activated kinase 2 (PAK2) (S197; 0.3) and glucosamine-fructose-6-phosphate aminotransferase [isomerizing] 1 (GFPT1) (T262; 0.6) were found to be hypo-phosphorylated upon curcumin treatment ( Figure 2 ). Our data indicate an orchestrated downregulation of CaMKK2 and its targets, suggesting that CaMKK2-mediated signalling could be one of the pathways through which curcumin mediates its anti-neoplastic effects. In this study, we determined whether targeting CaMKK2 and its downstream targets could serve as an alternative to curcumin in HNSCC patients. Representative MS/MS spectra of CaMKK2 and AMPK-b1 are given in Supplementary Figure 1 .
Curcumin inhibits invasion and colony forming ability of HNSCC cells
In our previous study, we showed that curcumin significantly inhibited colony forming and invasive ability of CAL 27 cells. Here, we studied the effects of curcumin on other HNSCC cells lines. We observed that treatment with curcumin led to decreased invasive and colony forming ability of HNSCC cell lines FaDu, JHU-O22 and JHU-O28 (Figure 3(a) to (d) ). In addition, curcumin was found to inhibit the proliferation of these cells (data not shown). Taken together, these results suggest that curcumin inhibits cellular proliferation, colony formation and invasive ability of HNSCC cells.
Inhibition or silencing of CaMKK2 reduces colony formation and invasion ability of HNSCC cells
We observed hypo-phosphorylation of CaMKK2 in CAL 27 cells upon curcumin treatment. We and others have shown the role of CaMKK2 as a therapeutic target in cancer; however, its role in HNSCC is poorly understood. We studied the effects of both silencing and inhibiting CaMKK2 in a panel of HNSCC cells. small interfering RNA (siRNA)-mediated silencing and inhibiting CaMKK2 using its inhibitor STO-609 led to a significant decrease in the colony formation ability of CAL 27 and other HNSCC cells (Figure 4 
Delineation of signalling pathways in CaMKK2-mediated effects
Having observed that CaMKK2 and its downstream targets, AMPK-b1 and acetyl-CoA carboxylase 1 (ACC1), hypophosphorylated upon curcumin treatment and that inhibition of CaMKK2 corroborates the phenotypic effects of curcumin, we sought to study the signalling mechanisms of CaMKK2. Western blot analysis confirmed hypo-phosphorylation of AMPK-b1 (S108) upon treatment with curcumin. However, the total levels of AMPK-b1 and CaMKK2 remained unchanged ( Figure 6(a) ). Since AMPK-a exists in complex with AMPK-b and Ca 2þ /CaM, and phosphorylation of AMPK-a at Thr-172 is essential for its activation, 22, 23 we determined the effects of curcumin on AMPK-a. Curcumin treatment resulted in hypo-phosphorylation of AMPK-a at T172 (Figure 6(a) ).
We next studied the effects of CaMKK2 silencing and inhibition on the signalling cascade using a panel of HNSCC cells, in addition to CAL 27. siRNA-mediated silencing of CaMKK2 led to a decreased phosphorylation of AMPK-a. However, the phosphorylation of AMPK-b1 remained unchanged upon silencing CaMKK2 (Figure 6(b) ). In agreement with the siRNA results, inhibition of CaMKK2 using its inhibitor STO-609 also showed a decreased phosphorylation of AMPK-a but not AMPK-b1 (Figure 6(c) ). Taken together, these results suggest that CaMKK2 corroborates the signalling pathway of curcumin and mediates its effects through AMPK-a.
Discussion
HNSCC is one of the most common cancers in India and sixth most common cancer worldwide. Despite improvements in diagnostic and therapeutic modalities, the clinical outcome/ prognosis remains poor with a 5-year survival rate being less than 50%. Therefore, new therapeutic targets are needed for the early diagnosis of disease and to improve patient survival. Multiple groups have evaluated the role of curcumin as an anti-cancer agent. However, the use of curcumin is limited due to its poor solubility and bioavailability. In this study, we evaluated the signalling pathways through which curcumin mediates its effects and identified proteins that could be targeted as an alternative to curcumin by mass spectrometrybased proteomic analysis. The current study demonstrates the anti-cancer effects of curcumin on HNSCC cells and signalling pathways through which it mediates its effects. This is the first high-throughput study to profile STKs and their downstream targets that are altered in response to curcumin. Curcumin is shown to affect the phosphorylation of MAPK1/3 and also reported to regulate the cleavage and activation of p21 (RAC1)-activated kinase 2 (PAK2). 10, [24] [25] [26] In addition, curcumin has also been reported to affect the autophosphorylation of epidermal growth factor receptor (EGFR) where it has also been shown to decrease phosphorylation of EGFR. 27, 28 Our group has studied dysregulation in tyrosine kinases in the same cell line, Cal 27, in response to curcumin. 10 Comparison between our previous study and this study revealed dysregulation of 66 proteins to be common between the two data sets. Various kinases including EGFR, EPH receptor A2 (EPHA2), PTK2 and EPH receptor B4 (EPHB4) were found to be dysregulated in both data sets, thus showing concordance between data published previously. In addition, we identified several STKs including CDC-like kinase 1 (CLK1), STK10, CaMKK2 and STK38 whose role are to be studied in curcumin-mediated effects. Although studies have reported the dysregulation of PTK2, its downstream targets were not reported. In our previous study, using phosphoproteomic-based mass spectrometry approach, we mapped the downstream targets of PTK2 pathway. 10 In the current study, in addition to PTK2 pathway, we have shown that curcumin can also mediate its effects through CaMKK2 and its downstream targets. Thus, the two studies together implicate that curcumin-mediated anti-neoplastic effects may be due to perturbations of PTK2 and CaMKK2-mediated signalling pathways. It is established that calcium (Ca 2þ ) binds to intercellular receptor, calmodulin (CaM), and regulate various cellular processes and pathways. [29] [30] [31] 35, 36 AMPK is an enzyme that plays a role in the regulation of energy homeostasis, cytoskeletal organization and cell cycle. 22 CaMKK2 has been shown to phosphorylate and activate protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1; AMPK-a) and these proteins exist as a complex with Ca 2þ /CaM and AMPK-b. 35, 37, 38 We evaluated the role of CaMKK2 as an alternative to curcumin (due to poor solubility and bioavailability) that could be targeted in HNSCC. Mass spectrometry analysis revealed hypo-phosphorylation of CaMKK2. Further, inhibition/siRNA-mediated silencing of CaMKK2 resulted in a significant reduction in colony formation and invasion ability of HNSCC cells. In addition to CaMKK2, mass spectrometry analysis also revealed the hypo-phosphorylation of downstream targets of CaMKK2, AMPK-b1 and ACC1 upon curcumin treatment of CAL 27 cells. Phosphorylation status of CaMKK2 upon curcumin treatment could not be evaluated by Western blotting due to unavailability of site-specific phospho-CaMKK2 antibody. However, Western blot analysis showed that the total levels of CaMKK2 remained unchanged upon curcumin treatment. AMPK-a exists in complex with AMPK-b and CaMKK2 and mediate signalling. Western blot analysis showed decreased phosphorylation of AMPK-a at T172 upon treatment with curcumin and on silencing or inhibition of CaMKK2, indicating that CaMKK2 may mediate its effects through AMPK-a. Taken together, these results indicate that curcumin mediates its effects through CaMKK2 and AMPK-a. Our current study does not rule out the role of other molecules and/or genomic factors towards curcuminmediated signalling. The findings of this study substantiate the crucial role of CaMKK2 in HNSCC and that it can serve as a potential therapeutic target in HNSCC. A detailed understanding of the function of CaMKK2 in HNSCC is needed, which requires evaluation in preclinical mouse models and is beyond the scope of this article. Our work provides a scaffold for future studies to systematically investigate the role of CaMKK2 in HNSCC, especially as an alternative to curcumin due to curcumin's poor solubility and bioavailability. Trust/DBT India Alliance Intermediate Career Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Remya Raja is a recipient of Startup research scheme from DST. We thank Dr. S. K. Shankar and Dr. Anita Mahadevan (NIMHANS), for providing access to the microscopy imaging facility.
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